Valneva SE
Specialty vaccine company developing and commercializing vaccines for infectious diseases.
VLA | PA
Overview
Corporate Details
- ISIN(s):
- AT0000A10B99 (+3 more)
- LEI:
- 969500DIVIP5VKNW4948
- Country:
- France
- Address:
- 6 RUE ALAIN BOMBARD, 44800 SAINT-HERBLAIN
- Website:
- https://valneva.com/
- Sector:
- Manufacturing
Description
Valneva SE is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet medical needs. The company has leveraged its expertise to commercialize three vaccines, including a single-shot vaccine for chikungunya. Its research and development pipeline features a broad range of vaccine candidates, including those targeting Lyme disease, Shigella, and Zika.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2018-11-19 22:15 |
2018_11_19_VLA_Emergent_ZIKA_Phase1_Results_PR_FR
|
French | 195.9 KB | ||
| 2018-11-08 07:00 |
2018_11_08_VLA_9Month2018_PR_EN
|
English | 781.4 KB | ||
| 2018-11-08 07:00 |
2018_11_08_VLA_9Month2018_PR_FR
|
French | 793.7 KB | ||
| 2018-11-05 18:00 |
Valneva Declaration octobre 2018
|
French | 182.5 KB | ||
| 2018-06-07 08:00 |
2018_06_07_AGM_Docs_PR_EN
|
English | 448.5 KB | ||
| 2018-06-07 08:00 |
2018_06_07_AGM_Docs_PR_FR
|
French | 450.0 KB | ||
| 2018-06-06 18:00 |
Valneva Declaration de mai 2018
|
French | 184.8 KB | ||
| 2018-05-07 18:01 |
Valneva - Déclaration Avril 2018
|
French | 184.0 KB | ||
| 2018-04-06 18:00 |
Valneva - Declaration mars 2018
|
French | 114.1 KB | ||
| 2018-03-29 09:30 |
2018_03_29_Valneva WVC PR_FR
|
French | 236.6 KB | ||
| 2018-03-29 09:30 |
2018_03_29_Valneva WVC PR_EN
|
English | 219.5 KB | ||
| 2018-03-22 07:00 |
2018_03_22_Valneva 2017 Registration Document PR_FR
|
French | 143.8 KB | ||
| 2018-03-19 07:00 |
2018_03_19_VLA15 Phase 1 Results_EN
|
English | 358.4 KB | ||
| 2018-03-19 07:00 |
2018_03_19_VLA15 Phase 1 Results_FR
|
French | 419.0 KB | ||
| 2018-03-13 17:45 |
2018_03_13_Chikungunya Phase 1 Initiation_EN
|
English | 336.8 KB |
Automate Your Workflow. Get a real-time feed of all Valneva SE filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Valneva SE
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Valneva SE via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-03-18 | N/A | Other | Buy | 44,222 | N/A |
| 2024-01-03 | N/A | Other | Other | 34,802 | N/A |
| 2023-06-20 | N/A | Other | Sell | 192,547 | 1,406,228.50 EUR |
| 2023-06-19 | N/A | Other | Sell | 30,661 | 209,629.26 EUR |
| 2023-06-16 | N/A | Other | Sell | 85,589 | 582,493.06 EUR |
| 2023-06-15 | N/A | Other | Sell | 28,179 | 189,503.78 EUR |
| 2023-06-14 | N/A | Other | Sell | 228,951 | 1,519,914.11 EUR |
| 2023-06-13 | N/A | Other | Sell | 29,401 | 187,922.37 EUR |
| 2023-06-12 | N/A | Other | Sell | 117,854 | 733,782.57 EUR |
| 2023-05-10 | N/A | Other | Buy | 87,523 | N/A |
Peer Companies
